Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) Notified -
urban-gro, Inc. Positions for Entry into Multi-Billion-Dollar T20 Cricket Market with LPL Season Six Player Auction on May 15, 2026 via IPG Platform Notified -
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate Notified -
How companies are reducing business travel emissions through small digital changes, according to Holafly for Business Notified -
iCAUR to Host International Business Summit During Auto China 2026, Showcasing Its New Energy System Strategy Notified -
Earth Month 2026: 42% of travelers say they take steps to travel more responsibly, according to Holafly Notified -
Global study shows energy industry ramping up investment in autonomous operations by 2030 as AI reshapes performance Notified -
